Mannose-binding lectin (MBL) in health and disease

Immunobiology

Volumn 199, Issue 2, 1998, Pages 327-339

  Turner, Malcolm W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C4; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LECTIN; MANNOSE BINDING PROTEIN; OLIGOMER; OLIGOSACCHARIDE; RECEPTOR PROTEIN; REGULATOR PROTEIN; SERINE PROTEINASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA SOUTH OF THE SAHARA; ASIA; BACTERIAL CELL WALL; CELL SURFACE; CODON; COMPLEMENT ACTIVATION; EUROPE; EXON; GENE CLUSTER; GENE MUTATION; GENOTYPE; HUMAN; IMMUNE DEFICIENCY; MICROORGANISM; PHAGOCYTE; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DOMAIN; PROTEIN SECONDARY STRUCTURE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TRIPLE HELIX; VIRUS CELL INTERACTION; VIRUS INFECTION;

EID: 0031720252     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(98)80037-5     Document Type: Article

References (48)

1. TURNER, M. W. 1996. Mannose binding lectin: the pluripotent molecule of the innate immune system. Immunol. Today 17: 532.
2. EPSTEIN, J., Q. EICHBAUM, S. SHERIFF, and R. A. B. EZEKOWITZ. 1996. The collectins in innate immunity. Curr. Opin. Immunol. 8: 29.
3. HOLMSKOV, U., R. MALHORTA, R. B. SIM, and J. C. JENSENIUS. 1994. Collectins: collagenous C-type lectins of the innate immune defence system. Immunol. Today 15: 67.
4. MATSUSHITA, M. and T. FUJITA. 1992. Activation of the classical complement pathway by mannose-binding protein in association with a novel Cls-like serine protease. J. Exp. Med. 176: 1497.
5. THIEL, S., T. VORUP-JENSEN, C. M. STOVER, W. SCHWAEBLE, S. B. LAURSEN, K. POULSEN, A. C. WILLIS, P. EGGLETON, S. HANSEN, U. HOLMSKOV, K. B. M. REID, and J. C. JENSENIUS. 1997. A second serine protease associated with mannan-binding lectin that activates complement. Nature 386: 506.
6. KUHLMAN, M., K. JOINER, and EZEKOWITZ. 1989. The human mannose-binding protein functions as an opsonin. J. Exp. Med. 169: 1733.
7. MALHOTRA, R., S. THIEL, K. B. REID, and R. B. SIM. 1990. Human leukocyte Clq receptor binds other soluble proteins with collagen domains. J. Exp. Med. 172: 955.
8. TENNER, A. J., S. L. ROBINSON, and R. A. B. EZEKOWITZ. 1995. Mannose-binding protein (MBP) enhances mononuclear phagocyte function via a receptor that contains the 126,000 m(r) component of the Clq receptor. Immunity 3: 485.
9. TABONA, P., A. MELLOR, and J. A. SUMMERFIELD. 1995. Mannose-binding protein is involved in first-line host-defense-evidence from transgenic mice. Immunology 85: 153.
10. SCHELENZ, S., R. MALHOTRA, R. B. SIM, U. HOLMSKOV, and G. J. BANCROFT. 1996. Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeasts. Infect. Immun. 63: 3360.
11. HAURUM, J. S., S. THIEL, I. M. JONES, P. B. FISCHER, S. B. LAURSEN, and J. C. JENSENIUS. 1993. Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. AIDS 7: 1307.
12. HARTSHORN, K. L., K. SASTRY, M. R. WHITE, E. M. ANDERS, M. SUPER, R. A. EZEKOWITZ, and A. I. TAUBER. 1993. Human mannose-binding protein functions as an opsonin for influenza A viruses. J. Clin. Invest. 91: 1414.
13. HARTSHORN, K. L., K. B. M. REID, M. R. WHITE, J. C. JENSENIUS, S. M. MORRIS, A. I. TAUBER, and E. CROUCH. 1996. Neutrophil deactivation by influenza A viruses: mechanisms of protection after viral opsonization with collectins and hemagglutination-inhibiting antibodies. Blood 87: 3450.
14. VAN EMMERIK, L. C., E. J. KUIJPER, C. A. FIJEN, J. DANKERT, and S. THIEL. 1994. Binding of mannan-binding protein to various bacterial pathogens of meningitis. Clin. Exp. Immunol. 97: 411
15. JACK, D. L., A. W. DODDS, N. ANWAR, C. A. ISON, A. LAW, M. FROSCH, M. W. TURNER, and N. J. KLEIN. 1998. Activation of complement by mannose-binding lectin on isogenic mutants of Neisseria meningitidis serogroup B. Journal of Immunology 160: 1346.
16. KLEIN, N. J., C. A. ISON, M. PEAKMAN, M. LEVIN, S. HAMMERSCHMIDT, M. FROSCH, and R. S. HEYDERMAN. 1996. The influence of capsulation and lipooligosaccharide structure on neutrophil adhesion molecule expression and endothelial injury by Neisseria meningitidis. J. Infect. Dis. 173:172.
17. MILLER, M. E., J. SEALS, R. KAYE, and L. C. LEVITZKY. 1968. A familial, plasma-associated defect of phagocytosis. Lancet ii: 60.
18. LEVINSKY, R. J., B. A. M. HARVEY, and S. PALEJA. 1978. A rapid objective method for measuring the yeast opsonisation activity of sera. J. Immunol. Meths. 24: 251.
19. YAMAMURA, M. and H. VALDIMARSSON. 1978. A new semiquantitative radiometric opsonin assay. Selective measurement of opsonising capacity of the alternative pathway. Immunology 34: 689.
20. KERR, M. A., J. S. FALCONER, A. BASHEY, and J. SWANSON BECK. 1983. The effect of C3 levels on yeast opsonization by normal and pathological sera: identification of a complement independent opsonin. Clin. Exp. Immunol. 54: 793.
21. WYKE, R. J., A. RAJKOVIC, and R. WILLIAMS. 1983. Impaired opsonisation by serum from patients with chronic liver disease. Clin. Exp. Immunol. 51: 91.
22. SUPER, M., S. THIEL, J. LU, R. J. LEVINSKY, and M. W. TURNER. 1989. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet ii: 1236.
23. SUMIYA, M., M. SUPER, P. TABONA, R. J. LEVINSKY, T. ARAI, M. W. TURNER, and J. A. SUMMERFIELD. 1991. Molecular basis of opsonic defect in immunodeficient children. Lancet 337: 1569.
24. BELLA, J., M. EATON, B. BRODSKY, and H. M. BERMAN. 1994. Crystal and molecular structure of a collagen-like peptide at 1.9 A resolution. Science 226: 75.
25. LIPSCOMBE, R. J., M. SUMIYA, J. A. SUMMERFIELD, and M. W. TURNER. 1995. Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype. Immunology 85: 660.
26. LIPSCOMBE, R. J., M. SUMIYA, A. V. HILL, Y. L. LAU, R. J. LEVINSKY, J. A. SUMMERFIELD, and M. W. TURNER. 1992. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene [published erratum appears in Hum Mol Genet 1993 Mar; 2 (3): 342]. Hum. Mol. Genet. 1: 709.
27. MADSEN, H. O., P. GARRED, A. L. JOERGEN, J. A. KURTZHALS, L. U. LAMM, L. P. RYDER, S. THIEL, and A. SVEJGAARD. 1994. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 40: 37.
28. MADSEN, H. O., P. GARRED, S. THIEL, J. A. L. KURTZHALS, L. U. LAMM, L. P. RYDER, and A. SVEJGAARD. 1995. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J. Immunol. 155: 3013.
29. GARRED, P., H. O. MADSEN, J. A. KURTZHALS, L. U. LAMM, S. THIEL, A. S. HEY, and A. SVEJGAARD. 1992. Diallelic polymorphism may explain variations of the blood concentration of mannan-binding protein in Eskimos, but not in black Africans. Eur. J. Immunogen. 19: 403.
30. LIPSCOMBE, R. J., D. W. BEATTY, M. GANCZAKOWSKI, E. A. GODDARD, T. JENKINS, Y. LAU, A. B. SPURDLE, M. SUMIYA, J. A. SUMMERFIELD, and M. W. TURNER. 1996. Mutations in the human mannan-binding protein gene: frequencies in several population groups. Eur. J. Hum. Genet. 4: 13.
31. GARRED, P., M. HARBOE, T. OETTINGER, C. KOCH, and A. SVEJGAARD. 1994. Dual role of mannan-binding protein in infections: Another case of heterosis. Eur. J. Immunogen. 21: 125.
32. EZEKOWITZ, R. A. B. 1991. Ante-antibody immunity. Curr. Opin. Immunol. 1: 60.
33. GARRED, P., H. O. MADSEN, B. HOFMANN, and A. SVEJGAARD. 1995. Increased frequency of homozygosity of abnormal mannan-binding protein alleles in patients with suspected immunodeficiency. Lancet 346: 941.
34. SUMMERFIELD, J. A., M. SUMIYA, M. LEVIN, and M. W. TURNER. 1997. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. British Medical Journal 314: 1229.
35. SUMMERFIELD, J. A., S. RYDER, M. SUMIYA, M. THURSZ, A. GORCHEIN, M. A. MONTEIL, and M. W. TURNER. 1995. Mannose-binding protein gene-mutations associated with unusual and severe infections in adults. Lancet 345: 886.
36. MEAD, R., D. JACK, M. PEMBREY, L. TYFIELD, M. TURNER, and THE ALSPAC STUDY TEAM. 1997. Mannose-binding lectin alleles in a prospectively recruited UK population. Lancet 349: 1669.
37. EZEKOWITZ, R. A. B., M. KUHLMAN, J. E. GROOPMAN, and R. A. BYRN. 1989. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J. Exp. Med. 169: 185.
38. NIELSEN, S. L., P. L. ANDERSEN, C. KOCH, J. C. JENSENIUS, and S. THIEL. 1995. The level of the serum opsonin, mannan-binding protein in HIV-1 antibody-positive patients. Clin. Exp. Immunol. 100: 219.
39. GARRED, P., H. O. MADSEN, U. BALSLEV, B. HOFMANN, C. PEDERSEN, J. GERSTOFT, and A. SVEJGAARD. 1997. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet 349: 236.
40. DAVIES, E. J., N. SNOWDEN, M. C. HILLARBY, D. CARTHY, D. M. GRENNAN, W. THOMSON, and W. E. OLLIER. 1995. Mannose-binding protein gene polymorphism in systemic lupus erythematosus. Arthritis Rheum. 38: 110.
41. LAU, Y. L., C. S. LAU, S. Y. CHAN, J. KARLBERG, and M. W. TURNER. 1996. Mannose-binding protein in Chinese with systemic lupus erythematosus. Arthritis & Rheumatism 39: 706.
42. MALHOTRA, R., M. R. WORMALD, P. M. RUDD, P. B. FISCHER, R. A. DWEK, and R. B. SIM. 1995. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nature Med. 1: 237.
43. GRAUDAL, N. A., C. HOMANN, H. O. MADSEN, A. SVEJGAARD, A. G. JURIK, H. K. GRAUDAL, and P. GARRED. 1998. Mannan-binding lectin in rheumatoid arthritis. A longitudinal study. Journal of Rheumatology 25: 629.
44. KILPATRICK, D. C., B. H. BEVAN, and W. A. LISTON. 1995. Association between mannan binding protein deficiency and recurrent miscarriage. Human Reprod. 10: 2501.
45. TURNER, M. W., M. SUPER, R. J. LEVINSKY, and J. A. SUMMERFIELD. 1991. The molecular basis of a common defect of opsonization. pp. 177-183. In Progress in Immune Deficiency III. Edit. H. M. Chapel, R. J. Levinsky, A. D. B. Webster, Royal Society of Medicine Services, London.
46. VALDIMARSSON, H., M. STEFANSSON, T. VIKINGSDOTTIR, G. J. ARASON, C. KOCH, S. THIEL, and J. C. JENSENIUS. 1998. Reconstitution of opsonizing activity by infusion of mannan-binding lectin (MBL) to MBL-deficient humans. Scand. J. Immunol. 48: (in press).
47. SOELL, M., E. LETT, F. HOLVECK, M. SCHOLLER, D. WACHSMANN, and J. P. KLEIN. 1995. Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD14 antigen, and mannan binding protein inhibits TNF-alpha release. J. Immunol. 154: 851.
48. CHAKA, W., A. F. M. VERHEUL, V. V. VAISHNAV, R. CHERNIAK, J. SCHARRINGA, J. VERHOEF. H. SNIPPE, and A. I. M. HOEPELMAN. 1997. Induction of TNF-in human peripheral blood mononucelar cells by the mannoprotein of Cryptococus neoformans involves human mannose binding protein. Journal of Immunology 159: 2979.